214 related articles for article (PubMed ID: 21681857)
1. N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.
Heibel SK; Ah Mew N; Caldovic L; Daikhin Y; Yudkoff M; Tuchman M
Hum Mutat; 2011 Oct; 32(10):1153-60. PubMed ID: 21681857
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
Williams M; Burlina A; Rubert L; Polo G; Ruijter GJG; van den Born M; Rüfenacht V; Haskins N; van Zutven LJCM; Tuchman M; Saris JJ; Häberle J; Caldovic L
Sci Rep; 2018 Oct; 8(1):15436. PubMed ID: 30337552
[TBL] [Abstract][Full Text] [Related]
3. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
[TBL] [Abstract][Full Text] [Related]
4. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of N-acetylglutamate synthase.
Heibel SK; Lopez GY; Panglao M; Sodha S; Mariño-Ramírez L; Tuchman M; Caldovic L
PLoS One; 2012; 7(2):e29527. PubMed ID: 22383952
[TBL] [Abstract][Full Text] [Related]
6. Short-term efficacy of N-carbamylglutamate in a patient with N-acetylglutamate synthase deficiency.
Kim JH; Kim YM; Lee BH; Cho JH; Kim GH; Choi JH; Yoo HW
J Hum Genet; 2015 Jul; 60(7):395-7. PubMed ID: 25787344
[TBL] [Abstract][Full Text] [Related]
7. N-acetylglutamate synthase: structure, function and defects.
Caldovic L; Ah Mew N; Shi D; Morizono H; Yudkoff M; Tuchman M
Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S13-9. PubMed ID: 20303810
[TBL] [Abstract][Full Text] [Related]
8. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.
Gessler P; Buchal P; Schwenk HU; Wermuth B
Eur J Pediatr; 2010 Feb; 169(2):197-9. PubMed ID: 19533169
[TBL] [Abstract][Full Text] [Related]
9. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles.
Caldovic L; Morizono H; Panglao MG; Lopez GY; Shi D; Summar ML; Tuchman M
Hum Mutat; 2005 Mar; 25(3):293-8. PubMed ID: 15714518
[TBL] [Abstract][Full Text] [Related]
10. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
[TBL] [Abstract][Full Text] [Related]
12. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.
Tuchman M; Caldovic L; Daikhin Y; Horyn O; Nissim I; Nissim I; Korson M; Burton B; Yudkoff M
Pediatr Res; 2008 Aug; 64(2):213-7. PubMed ID: 18414145
[TBL] [Abstract][Full Text] [Related]
13. Early treatment of a child with NAGS deficiency using N-carbamyl glutamate results in a normal neurological outcome.
Van Leynseele A; Jansen A; Goyens P; Martens G; Peeters S; Jonckheere A; De Meirleir L
Eur J Pediatr; 2014 Dec; 173(12):1635-8. PubMed ID: 24233332
[TBL] [Abstract][Full Text] [Related]
14. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
Kenneson A; Singh RH
Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
[TBL] [Abstract][Full Text] [Related]
15. A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency.
Olgac A; Kasapkara ÇS; Kilic M; Emine Derinkuyu B; Azapagasi E; Kesici S; Biberoğlu G; Ozyazici A; Karaca M; Haberle J
Arch Argent Pediatr; 2020 Dec; 118(6):e545-e548. PubMed ID: 33231058
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern and biochemical properties of zebrafish N-acetylglutamate synthase.
Caldovic L; Haskins N; Mumo A; Majumdar H; Pinter M; Tuchman M; Krufka A
PLoS One; 2014; 9(1):e85597. PubMed ID: 24465614
[TBL] [Abstract][Full Text] [Related]
17. Understanding N-Acetyl-L-Glutamate Synthase Deficiency: Mutational Spectrum, Impact of Clinical Mutations on Enzyme Functionality, and Structural Considerations.
Sancho-Vaello E; Marco-Marín C; Gougeard N; Fernández-Murga L; Rüfenacht V; Mustedanagic M; Rubio V; Häberle J
Hum Mutat; 2016 Jul; 37(7):679-94. PubMed ID: 27037498
[TBL] [Abstract][Full Text] [Related]
18. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia.
Caldovic L; Morizono H; Panglao MG; Cheng SF; Packman S; Tuchman M
Hum Genet; 2003 Apr; 112(4):364-8. PubMed ID: 12594532
[TBL] [Abstract][Full Text] [Related]
19. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy.
Elpeleg O; Shaag A; Ben-Shalom E; Schmid T; Bachmann C
Ann Neurol; 2002 Dec; 52(6):845-9. PubMed ID: 12447942
[TBL] [Abstract][Full Text] [Related]
20. A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
Senkevitch E; Cabrera-Luque J; Morizono H; Caldovic L; Tuchman M
Mol Genet Metab; 2012 Jun; 106(2):160-8. PubMed ID: 22503289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
